Skip to main content
    O

    Ovid Therapeutics Inc (OVID)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.40
    -0.14 (-5.51%)

    Market Cap: $479.38M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Ovid Therapeutics Inc (OVID) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Ovid Therapeutics (OVID) is expected to report earnings on Mar 16, 2027. In the quarter ended Sep 30, 2026, Ovid Therapeutics reported EPS of -$0.10, below the -$0.08 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    59%(23/39)
    Avg Surprise
    -1.36%

    Upcoming Estimates

    Reports Mar 16, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.10
    Range-$0.14 - -$0.08
    14 analysts
    Revenue Consensus
    $83.89K
    RangeN/A
    15 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.10
    Range-$0.11 - -$0.08
    4 analysts
    EPS Revisions
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.11+4.8%
    60d ago-$0.09-14.3%
    30d ago-$0.09-14.3%
    7d ago-$0.09-14.3%
    Current-$0.10
    Revenue Consensus
    $20.00K
    RangeN/A
    5 analysts

    Next Report

    OVID has an expected report date of Mar 16, 2027.

    Earnings History

    Of the 39 quarters below that had an estimate, OVID beat 23 and missed 16. The widest gap in the table came in the quarter ended Dec 31, 2023, when EPS landed 340.00% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.10-$0.08-$0.10 - -$0.05-25.00%MissN/A95 up, 0 downNov 10, 2026N/A
    Jun 30, 2026-$0.08-$0.10-$0.12 - -$0.10+20.00%BeatN/A70 up, 4 downAug 13, 2026$733000
    Mar 31, 2026-$0.12-$0.11-$0.15 - -$0.08-9.09%MissN/A51 up, 2 downMay 12, 2026N/A
    Dec 31, 2025$0.06-$0.11-$0.11 - -$0.09+152.77%BeatN/A51 up, 1 downMar 18, 2026$718000
    Sep 30, 2025-$0.17-$0.15-$0.17 - -$0.13-13.33%MissN/A50 up, 2 downNov 12, 2025$132000
    Jun 30, 2025-$0.06-$0.15-$0.16 - -$0.14+60.00%Beat-150.0%40 up, 2 downAug 13, 2025$6.27M
    Mar 31, 2025-$0.14-$0.13-$0.13 - -$0.13-7.69%MissN/A31 up, 0 downMay 13, 2025$130000
    Dec 31, 2024-$0.13-$0.17-$0.19 - -$0.15+22.20%BeatN/A42 up, 1 downMar 11, 2025$76000
    Sep 30, 2024-$0.20-$0.23-$0.29 - -$0.15+13.04%BeatN/A80 up, 0 downNov 12, 2024$173000
    Jun 30, 2024$0.12-$0.24-$0.26 - -$0.12+150.00%BeatN/A90 up, 0 downAug 13, 2024$169000
    Mar 31, 2024-$0.17-$0.23-$0.26 - -$0.17+26.09%BeatN/A80 up, 1 downMay 14, 2024$148000
    Dec 31, 2023-$0.22-$0.05-$0.17 - $0.25-340.00%MissN/A70 up, 0 downMar 8, 2024$142000
    Sep 30, 2023-$0.16-$0.19-$0.20 - -$0.17+15.79%BeatN/A61 up, 0 downNov 3, 2023$109000
    Jun 30, 2023-$0.18-$0.21-$0.22 - -$0.19+14.29%BeatN/A50 up, 0 downAug 4, 2023$75000
    Mar 31, 2023-$0.19-$0.17-$0.18 - -$0.16-11.76%MissN/A40 up, 0 downMay 5, 2023$66000
    Dec 31, 2022-$0.16-$0.18-$0.19 - -$0.17+11.11%BeatN/A40 up, 0 downMar 13, 2023$46280
    Sep 30, 2022-$0.17-$0.21-$0.23 - -$0.21+19.05%BeatN/A40 up, 0 downNov 8, 2022$11102
    Jun 30, 2022-$0.21-$0.25N/A+16.00%BeatN/AN/A0 up, 0 downAug 9, 2022N/A
    Mar 31, 2022-$0.20-$0.21-$0.22 - -$0.19+4.76%Beat-107.9%40 up, 0 downMay 10, 2022$1.45M
    Dec 31, 2021-$0.10-$0.16-$0.17 - -$0.15+37.50%BeatN/A4N/AMar 15, 2022N/A
    Sep 30, 2021-$0.17-$0.18-$0.21 - -$0.16+5.56%BeatN/A50 up, 0 downNov 10, 2021N/A
    Jun 30, 2021-$0.23-$0.16-$0.19 - -$0.12-43.75%MissN/A5N/AAug 16, 2021N/A
    Mar 31, 2021$2.53$1.13-$0.25 - $2.87+123.89%BeatN/A6N/AMay 13, 2021$208.38M
    Dec 31, 2020-$0.34-$0.31-$0.41 - -$0.10-9.68%MissN/A7N/AMar 15, 2021$5.70M
    Sep 30, 2020-$0.28-$0.35-$0.45 - -$0.05+20.00%BeatN/A7N/ANov 12, 2020$6.91M
    Jun 30, 2020-$0.41-$0.35-$0.38 - -$0.27-17.14%MissN/A7N/AAug 10, 2020N/A
    Mar 31, 2020-$0.37-$0.33-$0.38 - -$0.25-12.12%MissN/A8N/AMay 7, 2020N/A
    Dec 31, 2019-$0.35-$0.39-$0.48 - -$0.34+10.26%BeatN/A8N/AMar 11, 2020N/A
    Sep 30, 2019-$0.43-$0.36-$0.40 - -$0.34-19.44%MissN/A8N/ANov 8, 2019N/A
    Jun 30, 2019-$0.34-$0.40-$0.51 - -$0.35+15.00%BeatN/A7N/AAug 7, 2019N/A
    Mar 31, 2019-$0.46-$0.41-$0.54 - -$0.31-12.20%MissN/A7N/AMay 7, 2019N/A
    Dec 31, 2018-$0.52-$0.55-$0.62 - -$0.44+5.45%BeatN/A7N/AMar 7, 2019N/A
    Sep 30, 2018-$0.53-$0.61-$0.63 - -$0.55+13.11%BeatN/A5N/ANov 8, 2018N/A
    Jun 30, 2018-$0.53-$0.61-$0.68 - -$0.55+13.11%BeatN/A6N/AAug 9, 2018N/A
    Mar 31, 2018-$0.54-$0.53-$0.61 - -$0.41-1.89%MissN/A6N/AMay 8, 2018N/A
    Dec 31, 2017-$0.45-$0.41-$0.45 - -$0.38-9.76%MissN/A5N/AMar 29, 2018N/A
    Sep 30, 2017-$0.38-$0.54N/A+29.63%BeatN/AN/AN/ANov 9, 2017N/A
    Jun 30, 2017-$0.57-$0.48N/A-18.75%MissN/AN/AN/AAug 10, 2017N/A
    Mar 31, 2017-$3.48-$0.87N/A-300.00%MissN/AN/AN/AMay 5, 2017N/A
    Last 39 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.31, after -$0.38 the year before. It was -$4.88 for the year ended Dec 31, 2017, the oldest of the 9 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.31N/A
    Dec 31, 2024-$0.38N/A
    Dec 31, 2023-$0.75N/A
    Dec 31, 2022-$0.74-136.5%
    Dec 31, 2021$2.03N/A
    Dec 31, 2020-$1.40N/A
    Dec 31, 2019-$1.58N/A
    Dec 31, 2018-$2.12N/A
    Dec 31, 2017-$4.88N/A

    Frequently Asked Questions About OVID

    When is Ovid Therapeutics's next earnings date?

    Ovid Therapeutics's next earnings report is expected for Mar 16, 2027.

    Did OVID beat earnings estimates last quarter?

    No. Ovid Therapeutics reported EPS of -$0.10 for the quarter ended Sep 30, 2026, below the -$0.08 estimate by 25.00%.

    What EPS do analysts expect from OVID next quarter?

    The consensus EPS estimate for Ovid Therapeutics for the quarter ending Dec 31, 2026 is -$0.10 from 14 analysts, with estimates from -$0.14 to -$0.08.

    How often does OVID beat earnings estimates?

    Ovid Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +24.98%.